ArticleOrphanet journal of rare diseases2022
Fetal umbilical artery thrombosis: prenatal diagnosis, treatment and follow-up.
Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 26 citations in OpenAlex.
- Development and Validation of a Prenatal Doppler Hemodynamic-Clinical Risk Model for Predicting Adverse Perinatal Outcomes in Fetuses with Umbilical Artery Thrombosis.Journal of clinical medicine · 2026Article
- Gestational age-stratified management of umbilical artery thrombosis: a 5-year retrospective study at a tertiary referral center in China.BMC pregnancy and childbirth · 2026Article
- Umbilical Artery Thrombosis in the Third Trimester of Pregnancy: A Retrospective Analysis of 13 Cases.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2026Article
- Risk factors and adverse fetal outcomes in umbilical artery thrombosis: a comparison with single umbilical artery.BMC pregnancy and childbirth · 2025Article
- Umbilical Artery Thrombosis Masquerading as Single Umbilical Artery in a Stillbirth.Diagnostics (Basel, Switzerland) · 2025Article
- Risk Factors for Umbilical Artery Thrombosis in Pregnant Women: A Retrospective Study.International journal of women's health · 2025Article
- Evaluating the efficacy of low-molecular-weight heparin in managing umbilical artery thrombosis during pregnancy: does it offer therapeutic benefits?Frontiers in medicine · 2025Article
- From dual to single umbilical artery: a case of umbilical artery thrombosis with hypercoiling and literature review.Frontiers in medicine · 2025Article
- Article
- Hemodynamic changes and perinatal outcome associated with umbilical artery thrombosis: a retrospective study.Orphanet journal of rare diseases · 2024Article
- Umbilical artery thrombosis risk factors and perinatal outcomes.BMC pregnancy and childbirth · 2024Article
- Ultrasound blood flow characteristics changes in fetal umbilical artery thrombosis: A retrospective analysis.World journal of clinical cases · 2024Article
- Umbilical Vascular Thromboembolism: High-Risk Factors, Diagnosis, Management, and Pregnancy Outcomes: A Scoping Review.Therapeutics and clinical risk management · 2024Article
- Expectant management for umbilical artery thrombosis in the third trimester of pregnancy: a case report.Frontiers in pharmacology · 2024Article
- Expectant management for umbilical artery thrombosis in monochorionic diamniotic twin pregnancies: a case report.BMC pregnancy and childbirth · 2023Article
- Ductus Arteriosus Aneurysm and Pulmonary Artery Thromboses in a Protein S-Deficient Newborn.AJP reports · 2023Article
- Umbilical artery thrombosis and maternal positive autoimmune antibodies: two case reports and a literature review.Frontiers in medicine · 2023Article
- Umbilical Artery Thrombosis in Pregnancy: A Systematic Review and Case-based Insight into Doppler Diagnosis, Pathophysiology, and Perinatal Outcomes.Journal of medical ultrasoundReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo analyze the ultrasound imaging and clinical characteristics of fetuses with umbilical artery thrombosis (UAT), explore the potential causes of UAT and construct a prognostic prediction model to guide clinical practice.
methodsThis was a retrospective cohort study of fetal UAT cases examined at two academic tertiary referral care centers from 2014 to 2020. The basic information of the participants was obtained by interview during follow-up, and data on clinical treatment, delivery conditions, diagnosis and confirmation were obtained through medical records. Probable causes of thrombosis were explored by comparative analysis of the UAT group to the control group and by further regression analysis. Multivariable logistic regression models were used to evaluate risk factors for adverse pregnancy outcomes. Receiver operating characteristic (ROC) curves were constructed to evaluate the diagnostic value of the prognostic prediction model.
resultsThirty fetuses with UAT were included in this study. UAT occurred mostly in the third trimester of pregnancy, and there was an obvious predominance of right UAT. An abnormal pregnancy history (53.3%) was the most common comorbidity, followed by gestational diabetes mellitus (GDM) (20.0%). GDM and umbilical cord (UC) abnormalities were found to be independent risk factors for the development of UAT. After comprehensive decision-making, over two-thirds of the patients with UAT received urgent treatment, and less than one-third received expectant management. Surprisingly, there were no significant differences in fetal outcomes between the urgent treatment and expectant management groups. Multivariate logistic regression analysis showed that gestational age (GA) at clinical diagnosis and UC abnormalities were independent risk factors for adverse pregnancy outcomes (OR 0.781, p = 0.042; OR 16.779, p = 0.023, respectively). Based on this, we constructed a comprehensive prognostic prediction model. The area under the ROC curve (AUC) was 0.877 (95% CI 0.698-0.970; p < 0.001), which suggested that the combination of GA and UC abnormalities was a better predictor for fetal outcomes in our setting.
conclusionIn summary, maternal GDM and fetal UC abnormalities are independent risk factors for UAT. UAT is more frequently observed on the right side. Moreover, poor clinical outcomes for fetuses with UAT are ascribed mainly to GA and UC abnormalities, which should be comprehensively evaluated to choose the appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.